Clinical Trials
2 trialsNCT03126916 2026-02-27
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Children's Oncology Group
Phase 3 Recruiting
NCT04127110 2024-11-05
ALKALINE
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Active not recruiting